Guide to Submitting a Request for Ireland to act as RMS in a Decentralised Procedure for a Human Medicinal Product
10 March 2011
The Irish Medicines Board (IMB) wishes to actively participate as Reference Member State (RMS) in the decentralised procedure.
To date, the IMB receives many more requests than we are able to accommodate. In order ensure the IMB continues its commitment to act as RMS in as many procedures as possible and to continue to provide a high level of service to it its stakeholders, the IMB is introducing a new system for managing requests to act as RMS for 2011 and beyond.
A ‘window’ for requests for the IMB to act as RMS for DCP applications will open at least once a year inviting applications for submission during a specified time period. All requests will be considered and successful requests will be allocated a dedicated slot for assessment of the application. Requests received outside of these windows will not be accepted. If an applicant is unsuccessful in receiving a slot, they will need to reapply when the window reopens at a later date.
To read the guide in full, click on the link below:
Guide to Submitting a Request for Ireland to act as RMS in a Decentralised Procedure for a Human Medicinal Product
To view the most recent changes to this guide, click on the link below:
Guide to Submitting a Request for Ireland to act as RMS in a Decentralised Procedure for a Human Medicinal Product - changes tracked